Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cresco Labs Inc (OP:CRLBF)

1.200 +0.060 (+5.26%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cresco Labs Inc

< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Cresco Labs to Report Fourth Quarter 2024 Financial Results on March 12, 2025
From Cresco Labs
Via Business Wire
Michigan to Distribute Almost $100m from Cannabis Taxes to Communities
Via CannabisNewsWire
Topics Cannabis
Michigan to Distribute Almost $100m from Cannabis Taxes to Communities
Via Investor Brand Network
Topics Cannabis
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo. 
Via Benzinga
Topics Cannabis
Earnings Preview: Cresco Labs
 
Via Benzinga
Prohibitionists,  2 American Senators Work to Block 280E Relief for Marijuana Companies
Via CannabisNewsWire
Topics Cannabis
Missouri Courts Close to Completing Review of Marijuana Expungements
Via CannabisNewsWire
Topics Cannabis
California Data Breach Compromises 380,000 Customers’ Data
Via CannabisNewsWire
Topics Cannabis Data Breach
'President Trump's Endorsement Represents A Sea Change In Cannabis Policy,' Says Trulieve CEO As Advocacy Groups Join Forces
"Our new combined organization will best position the industry to help the President get them over the finish line," says Trulieve CEO Kim Rivers. 
Via Benzinga
Topics Cannabis Government
Medical Cannabis Patients in Arkansas Reach Record Numbers
Via CannabisNewsWire
Topics Cannabis
Cannabis Stock Movers For January 9, 2025
 
Via Benzinga
Topics Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
420 with CNW — Could the Growing Popularity of THC Drinks Push Alcohol Out of the US Market?
Via CannabisNewsWire
Topics Cannabis
420 with CNW — New Lawsuit Aims to Invalidate Nebraska’s Medical Marijuana Ballot Measures
Via CannabisNewsWire
Topics Cannabis Lawsuit
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government... 
Via Benzinga
Topics Cannabis
420 with CNW — Study: Utah’s Medical Cannabis Legalization Lowered Opioid Use by Patients with Chronic Pain
Via CannabisNewsWire
Topics Cannabis Death
Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip
ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales... 
Via Benzinga
Topics Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
420 with CNW — Key Lessons from the Marijuana Liberalization Journey of the US
Via CannabisNewsWire
Topics Cannabis
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%. 
Via Benzinga
Topics Cannabis
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. 
Via Benzinga
Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers
BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%. 
Via Benzinga
Topics Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56. 
Via Benzinga
Topics Cannabis ETFs Government
Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning
The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration. 
Via Benzinga
Topics Cannabis Government
420 with CNW — The GOP to Be Tested on its Readiness for Marijuana Policy Reform
Via CannabisNewsWire
Topics Cannabis Government
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment. 
Via Benzinga
Topics Cannabis Government
Cresco Labs Q3: Net Loss Reduced By 85% But EBITDA Also Declined By 5%
While the Florida initiative for cannabis legalization didn’t reach the 60% needed to pass (only 56%). 
Via Talk Markets
Topics Cannabis
Cannabis Co. Cresco Labs' 93% YoY Improvement In Net Loss, $49M Operating Cash Flow In Q3
resco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) a company behind Sunnyside dispensaries, released on Friday its financial and operating results for the third quarter ended September 30, 2024. Third... 
Via Benzinga
Topics Cannabis
Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results
From Cresco Labs
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.